LBPH
Longboard Pharmaceuticals#93 · 2024EPBYearly return
+139%
Peak return
+139%
Max drawdown
-44%
ADR (20 days)
+0.3%
Base
22 days / -44.6%
Prior run
+81%
Breakout volume
333.8x
Pivot
$6.50
Catalyst Analysten/Re-Rating2024-01-02There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price TargetBenzinga
Analysten- oder Re-Rating-Impuls, oft mit Momentum-Folgekaeufern.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare LBPH with the current market directly.